Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 9809817 Oligonucleotide compounds for targeting huntingtin mRNA

Patent 9809817 was granted and assigned to University of Massachusetts on November, 2017 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Current Assignee
University of Massachusetts
University of Massachusetts
Date Filed
April 1, 2016
Date of Patent
November 7, 2017
Patent Applicant
University of Massachusetts
University of Massachusetts
Patent Application Number
15089319
Patent Citations Received
‌
US Patent 12077755 Bioactive conjugates for oligonucleotide delivery
0
‌
US Patent 11753638 Conjugated oligonucleotides
‌
US Patent 11767527 Modified oligonucleotides targeting SNPs
‌
US Patent 11993774 Huntingtin (HTT) iRNA agent compositions and methods of use thereof
0
‌
US Patent 12006499 Una amidites and uses thereof
0
‌
US Patent 12024706 Modified oligonucleotides targeting SNPs
0
‌
US Patent 11702659 Optimized anti-FLT1 oligonucleotide compounds for treatment of preeclampsia and other angiogenic disorders
0
Patent Inventor Names
Julia Alterman
0
Neil Aronin
0
Anastasia Khvorova
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9809817
Patent Primary Examiner
‌
Tracy Vivlemore

Find more entities like US Patent 9809817 Oligonucleotide compounds for targeting huntingtin mRNA

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.